Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation

Thrombosis Research

Volumn 131, Issue 4, 2013, Pages 325-332

  Tseng, Yu Lun ^a   Chiang, Meng Ling ^b   Lane, Hsien Yuan ^a,c   Su, Kuan Pin ^a,c   Lai, Yu Chen ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antidepressant; Citalopram; P2Y12 receptor; Platelet aggregation; SSRI

Indexed keywords

ADENOSINE DIPHOSPHATE; AMFEBUTAMONE; CITALOPRAM; CYCLIC AMP; FLUOXETINE; PROTEIN KINASE B; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ARTICLE; CALCIUM MOBILIZATION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; THROMBOCYTE SHAPE; WESTERN BLOTTING;

ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; CITALOPRAM; HUMANS; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET AGGREGATION; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; SEROTONIN UPTAKE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 84875749757     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.02.007     Document Type: Article

References (32)

1. C.A. Stockmeier Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter J Psychiatry Res 37 2003 357 373
2. E. Maurer-Spurej Serotonin reuptake inhibitors and cardiovascular disease: a platelet connection Cell Mol Life Sci 62 2005 159 170
3. S.M. Stahl Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects J Affect Disord 51 1998 215 235
4. N. Hergovich, M. Aigner, H.G. Eichler, J. Entlicher, C. Drucker, and B. Jilma Paroxetine decreases platelet serotonin storage and platelet function in human beings Clin Pharmacol Ther 68 2000 435 442
5. A.I. Malinin, S. Ong, L.M. Makarov, E.Y. Petukhova, and V.L. Serebruany Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotension receptor blockers, statins and selective serotonin reuptake inhibitors Int J Clin Pract 60 2006 993 1002
6. B.N. Kahner, H. Shankar, S. Murugappan, G.L. Prasad, and S.P. Kunapuli Nucleotide receptor signaling in platelets J Thromb Haemost 4 2006 2317 2326
7. D. Li, S. August, and D.S. Woulfe GSK3β is a negative regulator of platelet function and thrombosis Blood 111 2008 3522 3530
8. 2 and inhibited by cGMP/cGMP-dependent protein kinase Blood 109 2007 616 618
9. E. Maurer-Spurej, C. Pittendreigh, and K. Solomons The influence of selective serotonin reuptake inhibitors on human platelet serotonin Thromb Haemost 91 2004 119 128
10. D. Atar, A. Malinin, A. Takserman, P. Alex, V.Z. Louis, and T. Jean-Francois Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans J Clin Psychopharmacol 26 2006 172 177
11. A.M. Galan, I. Lopez-Vilchez, M. Diaz-Ricart, F. Navalon, E. Gomez, and C. Gasto Serotonergic mechanisms enhance platelet-mediated thrombogenicity Thromb Haemost 102 2009 511 519
12. Y. Bismuth-Evenzal, Y. Gonopolsky, D. Gurwitz, I. Iancu, A. Weizman, and M. Rehavi Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs J Affect Disord 136 2012 99 103
13. Y.L. Tseng, M.L. Chiang, T.F. Huang, K.P. Su, H.Y. Lane, and Y.C. Lai A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation Thromb Res 126 2010 517 523
14. H. Hu, M. Forslund, and N. Li Influence of extracellular calcium on single platelet activation as measured by whole blood flow cytometry Thromb Res 116 2005 241 247
15. A. Cipriani, T.A. Furukawa, G. Salanti, J.R. Geddes, J.P.T. Higgins, and R. Churchill Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatment meta-analysis Lancet 373 2009 746 758
16. 3 and ADP receptors Blood 99 2002 193 198
17. 12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries J Clin Invest 112 2003 398 406
18. A.A. Weber, S. Reimann, and K. Schrör Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro Br J Pharmacol 126 1999 415 420
19. S.J. Mundell, M.L. Jones, A.R. Hardy, J.F. Barton, S.M. Beaucourt, and P.B. Conley Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function Mol Pharmacol 70 2006 1132 1142
20. U.R. Schwarz, J. Geiger, U. Walter, and M. Eigenthaler Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signaling transduction pathways in human platelets-definition and detection of ticlopidine/clopidogrel effects Thromb Haemost 82 1999 1145 1152
21. A.M.D. Carneiro, E.H. Cook, D.L. Murphy, and R.D. Blakely Interactions between integrin αIIbβ3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans J Clin Invest 118 2008 1544 1552
22. 12 receptor for adenosine diphosphate: congenital and drug-induced defects Blood 117 2011 2102 2112
23. i signaling pathways Biochem J 429 2010 369 377
24. J.M.E.M. Cosemans, I.C.A. Munnix, R. Wetzker, R. Heller, S.P. Jackson, and J.W. Heemskerk Continuous signaling via PI3K isoforms β and γ is required for platelet ADP receptor in dynamic thrombus stabilization Blood 108 2006 3045 3052
25. L. Zhou, and A.H. Schmaier Platelet aggregation testing in platelet-rich plasma. Description of procedures with the aim to develop standards in the field Am J Clin Pathol 123 2005 172 183
26. B. Boylan, C. Gao, V. Rathore, J.C. Gill, D.K. Newman, and P.J. Newman Identification of FcγRIIa as the ITAM-bearing receptor mediating αIIbβ3 outside-in integrin signaling in human platelets Blood 112 2008 2780 2786
27. M. Pavanetto, A. Zarpellon, C. Borgo, A. Donella-Deana, and R. Deana Regulation of serotonin transport in human platelets by tyrosine kinase Syk Cell Physiol Biochem 27 2011 139 148
28. A. Nurden, and P. Nurden Advances in our understanding of the molecular basis of disorders of platelet function J Thromb Haemost 9 Suppl. 1 2011 76 91
29. D.J. Walther, J.U. Peter, S. Winter, M. Höltje, N. Paulmann, and M. Grohmann Serotonylation of small GTPase is a signal transduction pathway that triggers platelet α-granule release Cell 115 2003 851 862
30. O.K. Fredricson Kinetics of citalopram in man; plasma levels in patients Prog Neuropsychopharmacol Biol Psychiatry 6 1982 311 318
31. Y. Bismuth-Evenzal, N. Roz, D. Gurwitz, and M. Rehavi N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor Biochem Pharmacol 80 2010 1546 1552
32. C. Labos, K. Dasgupta, H. Nedjar, G. Turecki, and E. Rahme Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction CMAJ 183 2011 1835 1843